[HTML] Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure
N Vodovar, MF Séronde, S Laribi, E Gayat, J Lassus… - JACC: Heart Failure, 2015 - Elsevier
Abstract Objectives This study sought to hypothesize that elevated B-type natriuretic peptide
(BNP) could act as an endogenous neprilysin inhibitor. Background A hallmark of acute
decompensated heart failure (ADHF) is the overproduction of natriuretic peptides (NPs) by
(BNP) could act as an endogenous neprilysin inhibitor. Background A hallmark of acute
decompensated heart failure (ADHF) is the overproduction of natriuretic peptides (NPs) by
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论